Trade MRKR anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Marker Therapeutics, Inc. (MRKR) is trading at US$1.41, down 3.42% today as of Aug 28, 12:53 EDT. The company has a market capitalisation of US$23.18M. Over the past 52 weeks, MRKR has traded between US$0.83 and US$2.46. On Syfe you can trade MRKR with $0 commission and add it to your watchlist.
| Previous close | US$1.46 |
|---|---|
| Market cap | US$23.18M |
| 52-week range | US$0.83 – US$2.46 |
| Volume | 24.51K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Marker Therapeutics, Inc.
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.
Year: 1998
Marker Therapeutics, Inc. (MRKR) stock is trading at US$1.41, -3.42% from the previous close of US$1.46.
The market cap for Marker Therapeutics, Inc. (MRKR) stock is approximately US$23.18M.
The 52-week high for Marker Therapeutics, Inc. (MRKR) stock is US$2.46.
The 52-week low for Marker Therapeutics, Inc. (MRKR) stock is US$0.83.
Marker Therapeutics, Inc. (MRKR) does not currently pay a dividend.
Stay on top of MRKR
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
